BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Webinar: hiPSC-based disease modeling & drug screening for neurodegenerative disorders

Webinar: hiPSC-based disease modeling & drug screening for neurodegenerative disorders

May 24, 2017 By Cade Hildreth (CEO) Leave a Comment

Applied StemCellHuman induced pluripotent stem cell (iPSC) technology offers the benefits of a cell line, coupled with the advantage of using human primary cells. Applied StemCell (ASC) has developed a panel of iPSC lines for neurotoxicity assays and disease modeling applications.

Discover class-defining bioproduction tools.

These cell lines include:

  1. Control lines
  2. Patient-specific lines
  3. Lineage-specific knock-in reporters
  4. Isogenic controls of single and double knock-outs

ASC has also established scalable protocols for generating differentiated cells in an assay-ready format.

Upcoming Webinar

Applied Stem Cell (ASC) Webinar iPSC-Neural Differentiation, astrocytes, oligodendrocytes and more

bitbio

In an upcoming webinar scheduled for Wednesday, May 31st, 2017, ASC will describe the utility of these lines for neurotoxicity assays, including assays to determine the specificity of different neural cell types for a small range of chemicals and drugs from the Tox21 library, as well as for neuroprotective assays with dopaminergic neurons.

Webinar Details:

Date: Wed, May 31, 2017
Time: 11:00 AM – 12:30 PM PDT
Length: Total 45 min

Click to Register

Additional iPSC-based Toolkits and Solutions

Applied StemCell is now offering comprehensive iPSC-based toolkits & solutions for all your neurological research and discoveries:

Pluristyx
    • Two control “master” iPSC lines: reprogrammed from male and female cord blood; karyotype normal, integration-free and footprint-free
      Click here for more info...Click here for more details.
    • Two panels of Isogenic neural stem cells, neurons & glial cells differentiated from each control iPSC line
      Click here for more info...Click here for more details.
    • Panels of Genome Engineered iPSC lines and differentiated lineages available from both control “master” lines:
      Click here for more info...Click here for more details.
    • Associated media and reagents

Also, available are fully customizable stem cell services, including:

    • iPSC generation from patient samples
    • iPSC genome editing
    • iPSC differentiation: neural lineage, cardiomyocytes, hepatocytes and more
    • Stem cell characterization: pluripotency markers, teratoma, karyotyping

To learn more, join ASC’s webinar on “Human iPSC-based disease modeling & drug screening for neurodegenerative disorders.”

5/5 - (3 votes)

Filed Under: iPS Cells, Stem Cell News Tagged With: Applied StemCell, webinar neural

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Tell Us What You Think! Cancel reply

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Featured Posts

Cord Blood Market Segmentation

Cord Blood Market Segmentation – Biobanking, HSCT, Cellular Therapy, Genetic Manipulation, & Research Tools

CAR-T Companies

CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide

Who discovered stem cells?

Who Discovered Stem Cells? The Answers Revealed

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.